Dow Down 0.25% Nasdaq Down 0.26%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.12 Down 0.10(2.37%) Aug 28, 4:00PM EDT
Prev Close:4.22
Open:4.21
Bid:4.05 x 1700
Ask:5.88 x 500
1y Target Est:7.06
Beta:-2.28
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.11 - 4.25
52wk Range:4.05 - 7.97
Volume:2,753,618
Avg Vol (3m):4,902,210
Market Cap:905.72M
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARNA

Comparison

Symbol% ChgMkt Cap
ARNADown 2.37%905.72M
GSKUp 0.41%117.39B
OREXDown 3.05%702.12M
RHHBYDown 0.19%248.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback